You are using an outdated browser. Please upgrade your browser to improve your experience.

lenvatinib

a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4)
Target Activities
Items per page:
10
1 – 7 of 7